Compare Pancaran Samudera Transport Tbk. (PSAT) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pancaran Samudera Transport Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Pancaran Samudera Transport Tbk. trades at Rp855 (market cap 1.26T, 227K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 9.3× Pancaran Samudera Transport Tbk.'s market cap, and Tempo Scan Pacific Tbk. is more actively traded (429.7K versus 227K). Which is the better fit depends on your goals.
| PSAT | TSPC | |
|---|---|---|
Market Cap | 1.26T | 11.68T |
Volume | 227K | 429.7K |
Lot | 2.27K | 4.3K |
Turnover | 188.83M | 1.11B |
Average Price | 831.85 | 2,591.65 |
Value | 188.83M | 1.11B |
Indicative Equilibrium Price | 855 | 2,580 |
Indicative Equilibrium Volume | 3 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pancaran Samudera Transport Tbk.
PT Pancaran Samudera Transport Tbk (the Company) was established on December 10, 2007 in the Republic of Indonesia based on the Notarial Deed No. 1 from Mary Maria, S.H, Notary in Depok. The Company commenced its operations in 2007. The Companys immediate parent company is PT Profitama Hasil Indah, incorporated and domiciled in Indonesia and its ultimate parent company is PT Pancaran Harapan Integra, also incorporated and domiciled in Indonesia.
Read more on PSAT →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
